OXFORD, UK; 14 July 2026 – CaniVax™ Limited, the leader in developing novel therapeutics to treat canine cancer, has today announced the appointment of Dr Thu Nguyen to lead its canine cancer vaccine programme. Dr Nguyen is a highly experienced…
Cancer treatment is evolving as scientists learn more about the biology of cancer and the immune system. While traditional therapies often focus on directly targeting tumour growth, newer approaches are exploring whether the immune system itself may become part of…
Cancer is not invisible to the immune system. The real question is why it is not always recognised. Immunopeptidomics offers a way to look directly at what cancer cells are showing to the immune system, and what may be going…
Personalised cancer vaccines are gaining attention, particularly with recent AI-driven examples. This article explains what is actually happening, and why a structured approach matters. 4 minute read In brief What people have seen Recent stories have highlighted cases where personalised…
OXFORD, UK; 4th February 2026 – The canine cancer vaccine company, CaniVax, today announced that it had secured significant investment from a group of established investors and entrepreneurs. The funding will enable CaniVax to advance its lead cancer vaccine towards…